Fingerprint
Dive into the research topics of 'Concomitant CYP2D6 inhibitor use and plasma metabolite levels in breast cancer patients treated with tamoxifen'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Concomitant CYP2D6 inhibitor use and plasma metabolite levels in breast cancer patients treated with tamoxifen
P. Fox, B. Balakrishnar, A. Menzies, C. Liddle, S. Coulter, P. Provan, V. Gebski, R. Hui, R. Kefford, N. Wilcken, R. Balleine, H. Gurney
Research output: Contribution to journal › Meeting abstract › peer-review